DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Herndon K, Guidry TJ, Wassell K, Elliott W.
Characterizing the safety profile of apixaban versus warfarin in moderate to severe chronic kidney disease at a Veterans Affairs hospital.
Ann Pharmacother 2020;
54 (06) 554-560
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.